Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brukinsa
Pharma
TROP2 ADCs, Merck-Daiichi, Eisai—Fierce Pharma Asia
The TROP2 ADC race between pharma giants is heating up. Merck and Daiichi partnered once again. Eisai inked a molecular glue degrader deal. And more.
Angus Liu
Aug 9, 2024 8:25am
AZ makes case for Calquence in another blood cancer type
Jun 17, 2024 11:25am
AZ clinches early Calquence win in untreated MCL
May 2, 2024 10:24am
BeiGene bumps AbbVie, J&J from top lymphoma event sponsor spot
Mar 12, 2024 12:03pm
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
Mar 7, 2024 4:08pm
BeiGene added 1,400 employees as key cancer drugs expand
Feb 26, 2024 11:03am
